Physician profile
Wayne Slocum
NPI 1083685242
$994.55
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $82.99 · 2021: $368 · 2022: $257.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.99 | 2019-2022 | |
| Aspira Women'S Health INC | $157.41 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $142.20 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.29 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $45.73 | 2021-2022 | |
| Organon LLC | $35.32 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.80 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.11 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.79 | 2019-2022 | |
| Daiichi Sankyo INC. | $16.86 | 2019 | |
| Therapeuticsmd, INC. | $15.09 | 2021 | |
| Avion Pharmaceuticals | $14.69 | 2022 | |
| Coopersurgical, INC. | $12.41 | 2019 | |
| Lupin INC. | $11.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Slocum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.